Targeted Treatment of Metastatic Breast Cancer by PLK1 siRNA Delivered by an Antioxidant Nanoparticle Platform.
about
The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis.Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer.Lack of acquired resistance in HER2-positive breast cancer cells after long-term HER2 siRNA nanoparticle treatment.Plk1 promotes the migration of human lung adenocarcinoma epithelial cells via STAT3 signaling
P2860
Targeted Treatment of Metastatic Breast Cancer by PLK1 siRNA Delivered by an Antioxidant Nanoparticle Platform.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Targeted Treatment of Metastat ...... oxidant Nanoparticle Platform.
@en
type
label
Targeted Treatment of Metastat ...... oxidant Nanoparticle Platform.
@en
prefLabel
Targeted Treatment of Metastat ...... oxidant Nanoparticle Platform.
@en
P2093
P2860
P1476
Targeted Treatment of Metastat ...... oxidant Nanoparticle Platform.
@en
P2093
David J Castro
Jingga Morry
Joe W Gray
Moataz Reda
Thanapon Sangvanich
Wassana Yantasee
Worapol Ngamcherdtrakul
P2860
P304
P356
10.1158/1535-7163.MCT-16-0644
P50
P577
2017-01-30T00:00:00Z